20
Participants
Start Date
January 10, 2018
Primary Completion Date
November 25, 2021
Study Completion Date
November 25, 2021
Stereotactic body RT with MR-guided boost
Patients will receive radiotherapy over 5 fractions delivered once per week over 29 days, with 7.25 Gy per fraction to the whole prostate and 8 Gy per fraction to the dominant intraprostatic lesion. There will be a minimum of 120 hours and maximum of 192 hours between fractions. The entire course of treatment should be completed within no less than 27 days and no longer than 30 days.
CancerCare Manitoba, Winnipeg
Lead Sponsor
CancerCare Manitoba
OTHER